Anti-SDK2 monoclonal antibody

Anti-SDK2 antibody for FACS & in-vivo assay

Target products collectionGo to SDK2/SDK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1497-Ab-1/ GM-Tg-hg-MP1497-Ab-2Anti-Human SDK2 monoclonal antibodyHuman
GM-Tg-rg-MP1497-Ab-1/ GM-Tg-rg-MP1497-Ab-2Anti-Rat SDK2 monoclonal antibodyRat
GM-Tg-mg-MP1497-Ab-1/ GM-Tg-mg-MP1497-Ab-2Anti-Mouse SDK2 monoclonal antibodyMouse
GM-Tg-cynog-MP1497-Ab-1/ GM-Tg-cynog-MP1497-Ab-2Anti-Cynomolgus/ Rhesus macaque SDK2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1497-Ab-1/ GM-Tg-felg-MP1497-Ab-2Anti-Feline SDK2 monoclonal antibodyFeline
GM-Tg-cang-MP1497-Ab-1/ GM-Tg-cang-MP1497-Ab-2Anti-Canine SDK2 monoclonal antibodyCanine
GM-Tg-bovg-MP1497-Ab-1/ GM-Tg-bovg-MP1497-Ab-2Anti-Bovine SDK2 monoclonal antibodyBovine
GM-Tg-equg-MP1497-Ab-1/ GM-Tg-equg-MP1497-Ab-2Anti-Equine SDK2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1497-Ab-1/ GM-Tg-hg-MP1497-Ab-2; GM-Tg-rg-MP1497-Ab-1/ GM-Tg-rg-MP1497-Ab-2;
GM-Tg-mg-MP1497-Ab-1/ GM-Tg-mg-MP1497-Ab-2; GM-Tg-cynog-MP1497-Ab-1/ GM-Tg-cynog-MP1497-Ab-2;
GM-Tg-felg-MP1497-Ab-1/ GM-Tg-felg-MP1497-Ab-2; GM-Tg-cang-MP1497-Ab-1/ GM-Tg-cang-MP1497-Ab-2;
GM-Tg-bovg-MP1497-Ab-1/ GM-Tg-bovg-MP1497-Ab-2; GM-Tg-equg-MP1497-Ab-1/ GM-Tg-equg-MP1497-Ab-2
Products NameAnti-SDK2 monoclonal antibody
Formatmab
Target NameSDK2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SDK2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SDK2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1497
    Target NameSDK2
    Gene ID54549,237979,360652,699027,483283,101095058,100336619,100061116
    Gene Symbol and Synonyms4632412F08Rik,5330435L01Rik,mKIAA1514,Sdk-2,SDK2
    Uniprot AccessionQ58EX2
    Uniprot Entry NameSDK2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000069188
    Target ClassificationN/A

    The target: SDK2, gene name: SDK2, also named as . The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains two immunoglobulin domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. This protein, and a homologous mouse sequence, are very similar to the Drosophila sidekick gene product but the specific function of this superfamily member is not yet known. Evidence for alternative splicing at this gene locus has been observed but the full-length nature of additional variants has not yet been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.